Peer Review History
| Original SubmissionMay 14, 2025 |
|---|
|
PGENETICS-D-25-00577 A simple method to efficiently generate structural variation in plants PLOS Genetics Dear Dr. Satyaki, Thank you for submitting your manuscript to PLOS Genetics. Your work raised significant interest among the editors, and there was a consensus that the technical quality of the study is high. However, some concerns were expressed regarding the novelty of the findings in their current form. Given the strong methodological component of your study, we believe it holds potential for publication as a Methods paper. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see the Additional Editor Comments at the end of this email for a summary of our suggested revisions. Please submit your revised manuscript within 60 days (August 17, 2025) . If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org at any time. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Mathilde Grelon Academic Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics Additional Editor Comments (if provided): Dear Dr Satyaki, Thank you for submitting your manuscript to PLOS Genetics. Your work raised significant interest among the editors, and there was a consensus that the technical quality of the study is high. However, some concerns were expressed regarding the novelty of the findings in their current form. Given the strong methodological component of your study, we believe it holds potential for publication as a Methods paper. To move forward, we would like to invite you to submit a thoroughly revised version of your manuscript that meets the criteria for a Methods article. These criteria include: - A clear and detailed description of the methodology, - Demonstration of the method’s utility and reproducibility, - Explanation of how the method advances or differs from existing approaches, - Relevance and applicability of the method to the research community. As the method for generating SVs is already common in non-plant systems, it would be important to highlight how your approach brings added value to the plant research community, and what specific advantages or innovations it offers in comparison to existing methodologies. We look forward to receiving a revised version of your manuscript tailored to these considerations. Sincerely yours Mathilde Grelon Journal Requirements: [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols |
| Revision 1 |
|
PGENETICS-D-25-00577R1 A simple method to efficiently generate structural variation in plants PLOS Genetics Dear Dr. Satyaki, Thank you for submitting your manuscript to PLOS Genetics. The reviewers appreciated the work but had some minor suggestions that could improve the manuscript. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please note that for manuscripts requiring minor revisions, the editor usually reviews the revised manuscript and response to reviewers, possibly in consultation with specific reviewers. We make every effort to shorten time to publication. Please submit your revised manuscript within 30 days. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Mathilde Grelon Academic Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics Additional Editor Comments (if provided): Reviewer #1: Reviewer #2: Reviewer #3: Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: The revision satisfies my criticism. Reviewer #2: I have to say that I was not involved in reviewing the first version of the paper. I read the revised manuscript as well as the rebuttal letter of the authors with interest. Using etoposide the authors are able to induce a larger number of structural variations in Arabidopsis , mainly insertion and deletions, which they also characterize by long read sequencing. The authors were able to correlate SVs with specific phenotypes, however not all SVs are correlated with phenotypic changes. These are interesting data and I regard them interesting for a large audience. Nevertheless, I feel that the authors are a bit too positive in the discussion comparing their results with irradiation mutagenesis. Moreover, in the last years the induction of directed Mb-sized SVs especially inversions by CRISPR/Cas has been achieved in a row of plant species and I think that this fact should be mentioned in the discussion, too Reviewer #3: This manuscript, “A simple method to efficiently generate structural variation in plants” by Bechen et al. presents an innovative approach to plant mutagenesis through chemical treatment with the topoisomerase II inhibitor etoposide. The authors show that, unlike commonly used chemical mutagens (e.g., EMS, sodium azide) that mainly induce SNPs, etoposide efficiently generates large structural variants (e.g., indels, inversions, duplications, and translocations) while maintaining wild-type-like SNV frequencies. This method represents a promising alternative to irradiation, offering a more accessible method for inducing complex mutations relevant for plant biology and breeding. The study combines phenotypic characterization, whole-genome sequencing (both short and long reads), and transcriptome analysis to identify structural variants and potential causal mutations. The manuscript is clearly written, well-illustrated, and supported by thorough experimental work that strongly supports authors conclusions. Overall, the manuscript introduces a novel, valuable and broadly applicable tool for generating genomic structural variation in plants, with strong potential to impact both fundamental research and applied breeding. I only have a couple of minor comments on the data and interpretation: - While the method shows promise, its applicability may be limited by the need for sustained exposure to the inhibitor, which may be less practical in certain contexts compared to radiation. My recollection is that etoposide is relatively unstable in solution and light sensitive. I therefore wonder whether etoposide remains active after several days (up to 2 weeks)? This could explain the varied efficiency of etoposide treatment reported by the authors. Did the authors attempted repeated or renewed etoposide treatments after for example 1 week (e.g. by adding fresh etoposide in the medium if transferring to new plates is tedious)? Or by treating few days after germination? (Since treatment requires active DNA replication, applying it directly to seeds may not be optimal). Minor point : Cytotoxic drugs usually require neutralization for safe disposal. However, there is no mention of such procedure in the method. Was any neutralization procedure applied that is worth mentioning? - Line 214- 218 : The text gives impression that DSBs leads to SNV. However, my understanding is that while a DSB can theoretically be repaired in a way that leads to just a single-base substitution, this is not the most common outcome. Instead, DSB repair most often results in small insertions or deletions due to non-homologous end joining NHEJ and/or Microhomology-mediated end joining, or, as described by the authors in the manuscript, larger structural variants (SVs) such as inversions, duplications, or translocations. All events observed and described by the authors are > 35 bp. Have the authors checked for small Indels (2-30 bp) typically associated with end-joining ? (Of note, cells lacking NHEJ factors are usually hypersensitive to etoposide). - Line 297-303 : Do the authors have any comments on the upregulation of meiotic genes in Virescent plant leaves? Are these plants later affected in fertility? - Table S7-to S9 provide the complete RNAseq data. However, the authors might also consider including a list containing only the few deregulated genes, which would be more straightforward to interpret for the reader. ********** Have all data underlying the figures and results presented in the manuscript been provided? Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy , and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: Reproducibility: To enhance the reproducibility of your results, we recommend that authors deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols |
| Revision 2 |
|
PGENETICS-D-25-00577R2 A simple method to efficiently generate structural variation in plants PLOS Genetics Dear Drs Gehring and Satyaki, Thank you very much for this revised version of your manuscript. It is almost ready for PLOS Genetics's publication but we would like to ask you to add details in your answer to Reviewer2/comment 2: please add the relevant references to support the added sentence: " Our method will generate mutant libraries that can be used directly for research or breeding, or provide targeting information for CRISPR-based tools that have recently created mega-base scale SVs in crop species (REFS) " Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript as soon as you can ( before the 12/12/25). If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Mathilde Grelon Academic Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics Additional Editor Comments (if provided): Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: Reproducibility: To enhance the reproducibility of your results, we recommend that authors deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols |
| Revision 3 |
|
Dear Dr Satyaki, We are pleased to inform you that your manuscript entitled "A simple method to efficiently generate structural variation in plants" has been editorially accepted for publication in PLOS Genetics. Congratulations! Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made. Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org. In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics! Yours sincerely, Mathilde Grelon Academic Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics BlueSky: @plos.bsky.social ---------------------------------------------------- Comments from the reviewers (if applicable): ---------------------------------------------------- Data Deposition If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository . As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website . The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-25-00577R3 More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support. Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present. ---------------------------------------------------- Press Queries If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org . |
| Formally Accepted |
|
PGENETICS-D-25-00577R3 A simple method to efficiently generate structural variation in plants Dear Dr Gehring, We are pleased to inform you that your manuscript entitled " A simple method to efficiently generate structural variation in plants" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work! With kind regards, Zsofia Freund PLOS Genetics On behalf of: The PLOS Genetics Team Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom plosgenetics@plos.org | +44 (0) 1223-442823 plosgenetics.org | Twitter: @PLOSGenetics |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .